Filing metadata

Accession number
0001104659-18-020444
Form type
Form 3
Filer
Nabriva Therapeutics plc
CIK
CIK 1641640
Filed
Mar 27, 2018
Reporting period
Mar 21, 2018
Description
Initial ownership

Explore SEC Filings Hub